Supernus Pharmaceuticals (SUPN) Tax Rate (2011 - 2026)
Supernus Pharmaceuticals' (SUPN) quarterly Tax Rate came in at 1.25% in Q2 2026, up 3372.0% year-over-year from 0.04% in Q2 2025, and up 98.92% quarter-over-quarter from 115.99% in Q4 2025.
Analysis
Supernus Pharmaceuticals (SUPN) Tax Rate (2011 - 2026) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has reported Tax Rate for 13 consecutive years, with 1.25% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Tax Rate rose 3372.0% year-over-year to 1.25% in Q2 2026; TTM through Jun 2026 was 15.59%, a 585.0% decrease from a year earlier, with the FY2025 full-year figure at 21.37%, down 315.0% from the prior year.
- Tax Rate was 1.25% for Q2 2026 at Supernus Pharmaceuticals, up from 115.99% in the prior quarter.
- Over five years, Tax Rate peaked at 495.5% in Q3 2022 and troughed at 115.99% in Q4 2025.
- A 5-year average of 36.86% and a median of 22.15% in 2025 frame the typical range for Tax Rate.
- Across the five-year window, Tax Rate surged 46995 bps in 2022 and tumbled 24756 bps in 2024, its largest moves.
- Over 5 years, Tax Rate stood at 27.49% in 2022, then sank by 168 bps to 18.69% in 2023, then surged by 323 bps to 41.71% in 2024, then sank by 378 bps to 115.99% in 2025, then jumped by 99 bps to 1.25% in 2026.
- The last three Tax Rate figures came in at 1.25% (Q2 2026), 115.99% (Q4 2025), and 22.15% (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.70 Bn | 621.95 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 440.80 Bn | 434.23 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -95.75% |
| 4 | Novartis Ag | 266.37 Bn | 258.68 Bn | 11.24 Bn | -23.71% |
| 5 | Pfizer | 158.89 Bn | 147.19 Bn | 10.94 Bn | 62.33% |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | -31.96% |
| 7 | Revolution Medicines | 44.38 Bn | 44.38 Bn | - | - |
| 8 | Incyte | 25.28 Bn | 20.74 Bn | 1.57 Bn | 22.08% |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 10.65% |
| 10 | Supernus Pharmaceuticals | 2.42 Bn | 2.05 Bn | 185.39 Mn | -1.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.25% |
| Dec 31, 2025 | -115.99% |
| Sep 30, 2025 | 22.15% |
| Jun 30, 2025 | -34.98% |
| Mar 31, 2025 | -102.90% |
| Dec 31, 2024 | 41.71% |
| Sep 30, 2024 | 14.34% |
| Jun 30, 2024 | 24.33% |
| Mar 31, 2024 | 48.97% |
| Dec 31, 2023 | -18.69% |
| Sep 30, 2023 | 261.91% |
| Jun 30, 2023 | 95.17% |
| Mar 31, 2023 | -87.96% |
| Dec 31, 2022 | 27.49% |
| Sep 30, 2022 | 495.50% |
| Jun 30, 2022 | 30.91% |
| Mar 31, 2022 | -74.03% |
| Dec 31, 2021 | -19.06% |
| Sep 30, 2021 | 25.55% |
| Jun 30, 2021 | 24.04% |